Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression

Abstract Background Several studies have suggested that antiplatelet (AP) or anticoagulant (AC) therapy may improve outcome in men with prostate cancer. We evaluated the effects of AP/AC therapy and tested the hypothesis that platelet count may also be associated with outcomes. Methods A total of 48...

Full description

Saved in:
Bibliographic Details
Main Authors: Stanley I. Gutiontov, Kevin S. Choe, Jonathan L. Miller, Stanley L. Liauw
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Cancer Medicine
Subjects:
blood platelets
prostatic neoplasms
radiotherapy
Online Access:https://doi.org/10.1002/cam4.3087
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items